← Leaderboards
Glenn J Bubley
Beth Israel Deaconess Medical Center
$139,391
Attributed
$139,391
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $95.4K · FY2012–13$100K$75K$50K$25K$0
'12
'13
Funding mix
By agency
NIH$139,391 · 3
By mechanism
U10$139,391 · 1
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Richard A. Hodin$11,784,355
- Michael B Atkins$4,622,469
- Ted J Kaptchuk$14,512,344
- Roy Freeman$22,152,212
- Frank W Sellke$18,106,428
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectProstate NeoplasmsDrug Screening /EvaluationClinical Trial Phase ICombination ChemotherapyInterleukin 2Neoplasm /Cancer ChemotherapyDrug Adverse EffectNeoplasm /Cancer ImmunotherapyAminoglutethimideChimeric ProteinsCortisolCytokineHormone TherapyPharmacokineticsDosageCommitCancer CenterFundingClinical TrialsBreastAnticancer Research
Grant awards (12)
Eastern Cooperative Oncology Group$43,980
U10 · FY2013 · CA · contact PI
Eastern Cooperative Oncology Group$95,411
U10 · FY2012 · CA · contact PI
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER$0
M01 · FY2002 · RR
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA$0
M01 · FY2002 · RR
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER$0
M01 · FY2001 · RR
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA$0
M01 · FY2001 · RR
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER$0
M01 · FY2000 · RR
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER$0
M01 · FY2000 · RR
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA$0
M01 · FY2000 · RR
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA$0
M01 · FY2000 · RR
SEQUENTIAL HORMONAL THERAPY FOR ANDROGEN INDEPENDENT PROSTATE CANCER$0
M01 · FY2000 · RR
TRIAL OF PFHUK5 IL 2 IMMUNOCYTOKINE FUSION IN PROSTATE CARCINOMA$0
M01 · FY2000 · RR